Moreover, the immunoblotting and quantitative analysis revealed that peritoneal dialysate increased the expression of peritoneal fibrosis proteins (Fibronectin, COL1A2, and α-SMA) in rats, while Canagliflozin treatment decreased their levels (Figures 5A,B). The gene discussed is COL1A2; the disease is Peritoneal Fibrosis.